Finanzen von American Vanguard Corporation (AVD)AVDAmerican Vanguard Corporation

American Vanguard Corporation (AVD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Herbicides/soil fumigants/fungicides, accounting for 50.7% of total sales, equivalent to $66.18M. Other significant revenue streams include Insecticides and Non-crop, including distribution. Understanding this composition is critical for investors evaluating how AVD navigates market cycles within the Agricultural Chemicals industry.

Evaluating the bottom line, American Vanguard Corporation maintains a gross margin of 27.13%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.38%, while the net margin is -8.45%. These profitability ratios, combined with a Return on Equity (ROE) of -26.48%, provide a clear picture of how effectively AVD converts its operational activities into shareholder value.

In the context of the broader market, AVD competes directly with industry leaders such as FNUC and BIOX. With a market capitalization of $62.54M, it holds a leading position in the sector. When comparing efficiency, AVD's gross margin of 27.13% stands against FNUC's N/A and BIOX's 30.10%. Such benchmarking helps identify whether American Vanguard Corporation is trading at a premium or discount relative to its financial performance.

The company has shown a consistent trend of negative net income, with the latest reported net income of -9,868,000 USD for Q2 2026. The gross margin has fluctuated, with a recent figure of 27.13%, but overall profitability remains a concern.